DiscoverMarkets & Money Today | 2 Min News | The Daily News Now!Johnson & Johnson Acquires Halda Therapeutics for $3.05B
Johnson & Johnson Acquires Halda Therapeutics for $3.05B

Johnson & Johnson Acquires Halda Therapeutics for $3.05B

Update: 2025-11-17
Share

Description

Johnson and Johnson bolsters its oncology portfolio with Halda Therapeutics acquisition, focusing on prostate cancer and other solid tumors.

The Daily News Now! — Every city. Every story. AI-powered.


Hosted on Acast. See acast.com/privacy for more information.

Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Johnson & Johnson Acquires Halda Therapeutics for $3.05B

Johnson & Johnson Acquires Halda Therapeutics for $3.05B